Medicine recalls
|
| |
| Singapore: Recall of Apo-Mometasone (mometasone) Aqueous Nasal Spray 50mcg/metered spray |
| |
Health Sciences Authority (HSA) announces that Pharmaforte Singapore Pte Ltd is recalling one batch of Apo-Mometasone Aqueous Nasal Spray 50mcg/metered spray (batch number: TX5343) to the retail level. The batch was recalled due to potential presence of Burkholderia cepacia complex. As a precautionary measure, the company is voluntarily recalling the affected batch.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/announcements/product-recall/recall-of-apo-mometasone-(mometasone)-aqueous-nasal-spray-50mcg-metered-spray
In Hong Kong, Apo-Mometasone Aqueous Nasal Spray 50mcg/metered spray (HK-62898) is a pharmaceutical product registered by Hind Wing Co Ltd (Hind Wing). The product is a prescription-only medicine. On 16 Feb 2024, the Department of Health (DH) endorsed Hind Wing to recall one batch of Apo-Mometasone Aqueous Nasal Spray 50mcg/metered spray (HK-62898) (batch number: TX5343) from the market as a precautionary measure due to potential quality issue. A recall statement was posted on the Drug Office website on the same date.
Ends/Friday, Feb 16, 2024
Issued at HKT 18:00
|
| |
|
